Contact US | Chinese
You Position: Home > Journal issue
Drug Evaluation Drug Evaluation

2023:

2022:

2021:

2020:

2019:

2018:

2017:

2016:

2015:

2014:

2013:

2012:

2011:

2010:

2009:

2008:

2007:

2006:

2005:

2004:

Drug Evaluation

Items 1-5 of 11
«Preious | of 3 |
1

Insulin aspart 30 can be applied in thewhole-course of type 2 diabetes therapy

Drug Evaluation, , Issue 21,2015, Pages 21-25, doi:10.3969/j.issn.1672-2809.2015.21.006

2

速读

Drug Evaluation, , Issue 21,2015, Pages 4-5,

3

Insulin aspart 30：the ideal choice of type 2 diabetes patients in China

Drug Evaluation, , Issue 21,2015, Pages 17-20,34, doi:10.3969/j.issn.1672-2809.2015.21.005

4

The selection in type 2 diabetes of treatment failure with Basal Insulin

Drug Evaluation, , Issue 21,2015, Pages 10-13,29, doi:10.3969/j.issn.1672-2809.2015.21.003

5

T he application and exploration of basicinsulin in gestational diabetes mellitus

Drug Evaluation, , Issue 21,2015, Pages 26-29, doi:10.3969/j.issn.1672-2809.2015.21.007

Items 1-5 of 11
«Preious | of 3 |
WanfangData CO.,Ltd All Rights Reserved
About WanfangData | Contact US
Healthcare Department, Fuxing Road NO.15, Haidian District Beijing, 100038 P.R.China
Tel:+86-010-58882616 Fax:+86-010-58882615 Email:yiyao@wanfangdata.com.cn